HOME >> BIOLOGY >> NEWS
NCI and NHGRI launch comprehensive effort to explore cancer genomics

What: The National Cancer Institute and the National Human Genome Research Institute will host a press conference to launch a human cancer genome pilot project. The project will lay the foundation for exploring genomic changes involved in cancer, with the ultimate goal of developing new means of preventing, detecting and treating cancer.

Who: Francis S. Collins, M.D., Ph.D., NHGRI director
Anna D. Barker, Ph.D., NCI deputy

When: Tuesday, December 13, 2005, 9:30 -10:30 a.m. EST

Where: Ballroom, National Press Club, 529 14th Street NW, Washington, D.C.

Note: Reporters may listen via teleconference by calling 1-800-479-9001 and entering the participant code: 9281704. Please dial in to the press conference 5 to 10 minutes prior to the scheduled start time.


'"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-451-8325
NIH/National Human Genome Research Institute
13-Dec-2005


Page: 1

Related biology news :

1. NHGRI funds large-scale sequencing centers
2. Lehigh scientist receives NHGRI grant to streamline, expand use of genome sequencing
3. NHGRI aims to make DNA sequencing faster, more cost effective
4. NHGRI awards $54 million to three Centers of Excellence in Genomic Science
5. NHGRI announces latest sequencing targets
6. NHGRI announces new sequencing targets
7. NHGRIs large-scale sequencing research network sets its sights on disease targets
8. NHGRI expands effort to revolutionize sequencing technologies
9. NHGRI selects 13 new targets for large-scale sequencing program
10. NHGRI targets 12 more organisms for genome sequencing
11. NHGRI seeks next generation of sequencing technologies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NCI and NHGRI launch comprehensive effort explore cancer genomics

(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)...  Unchained Labs just can,t get enough biologics ... Nano. Avid Nano designs, develops and manufactures highly ... Also today, Unchained Labs UNcaged the pUNk, ... protein sizing system. The pUNk is a high-performance ... size distribution, aggregation population and molecular weight. Its ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
(Date:7/28/2015)... ... ... VetStem Biopharma will be offering weekly private guided tours of our new ... The tour and course will be given every Wednesday at 6pm to local interested ... members are welcome to attend with their veterinarian as well. Participants will be able ...
(Date:7/28/2015)... 28, 2015 Tauriga Sciences, Inc. (OTCQB:  TAUG) ... company, today announced that its stockholders approved an increase ... of the Company from 1,000,000,000 to 2,500,000,000 at its ... at the Law Offices of Nixon Peabody LLP in ... there were 480,655,929 shares of common stock represented either ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix ... Phase 1 clinical trial with MMI-0100, a first-in-class ... being developed for pulmonary disorders characterized by inflammation ... United Kingdom , is a double-blind, ... evaluating the safety and tolerability of MMI-0100 when ...
(Date:7/28/2015)... , July 28, 2015 CSL Behring ... Administration has accepted for review the company,s Biologics License ... single-chain (rVIII-SingleChain) for the treatment of hemophilia A. In ... Hemophilia A is a ... VIII; nearly all affected patients are male. People with ...
Breaking Biology Technology:VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
Cached News: